Seguir
Rodrigo A Bressan
Rodrigo A Bressan
Professor Adjunto Livre Docente, Universidade Federal de São Paulo
Dirección de correo verificada de unifesp.br
Título
Citado por
Citado por
Año
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ...
Nature 604 (7906), 502-508, 2022
10812022
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
9002017
Cannabis use before age 15 and subsequent executive functioning
MA Fontes, KI Bolla, PJ Cunha, PP Almeida, F Jungerman, RR Laranjeira, ...
The British Journal of Psychiatry 198 (6), 442-447, 2011
3602011
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ...
Molecular psychiatry 11 (2), 118-119, 2006
3412006
The role of dopamine in reward and pleasure behaviour–review of data from preclinical research
RA Bressan, JA Crippa
Acta Psychiatrica Scandinavica 111, 14-21, 2005
3402005
A general psychopathology factor (P factor) in children: Structural model analysis and external validation through familial risk and child global executive function.
MM Martel, PM Pan, MS Hoffmann, A Gadelha, MC do Rosário, JJ Mari, ...
Journal of abnormal psychology 126 (1), 137, 2017
2782017
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions ...
Schizophrenia bulletin 40 (4), 729-736, 2014
2732014
High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results
GA Salum, A Gadelha, PM Pan, TS Moriyama, AS Graeff‐Martins, ...
International journal of methods in psychiatric research 24 (1), 58-73, 2015
1852015
Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia
WHL Pinaya, A Gadelha, OM Doyle, C Noto, A Zugman, Q Cordeiro, ...
Scientific reports 6 (1), 38897, 2016
1782016
The impact of epidemic violence on the prevalence of psychiatric disorders in Sao Paulo and Rio de Janeiro, Brazil
WS Ribeiro, JJ Mari, MI Quintana, ME Dewey, S Evans-Lacko, LMP Vilete, ...
PloS one 8 (5), e63545, 2013
1702013
Impact of childhood stress on psychopathology
E Brietzke, M Kauer-Sant'anna, A Jackowski, R Grassi-Oliveira, J Bucker, ...
Brazilian Journal of Psychiatry 34, 480-488, 2012
1542012
Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial
MQ Hoexter, FL de Souza Duran, CC D'alcante, DD Dougherty, ...
Neuropsychopharmacology 37 (3), 734-745, 2012
1472012
Structural validity and reliability of the Positive and Negative Affect Schedule (PANAS): evidence from a large Brazilian community sample
HW Carvalho, SB Andreoli, DR Lara, CJ Patrick, MI Quintana, RA Bressan, ...
Brazilian Journal of Psychiatry 35, 169-172, 2013
1462013
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients
RA Bressan, K Erlandsson, HM Jones, R Mulligan, RJ Flanagan, PJ Ell, ...
American Journal of Psychiatry 160 (8), 1413-1420, 2003
1452003
Ventral striatum functional connectivity as a predictor of adolescent depressive disorder in a longitudinal community-based sample
PM Pan, JR Sato, GA Salum, LA Rohde, A Gadelha, A Zugman, J Mari, ...
American Journal of Psychiatry 174 (11), 1112-1119, 2017
1382017
Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis
C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ...
International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015
1332015
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study
JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ...
Psychopharmacology 197, 401-408, 2008
1322008
Towards a multifactorial approach for prediction of bipolar disorder in at risk populations
E Brietzke, RB Mansur, JK Soczynska, F Kapczinski, RA Bressan, ...
Journal of affective disorders 140 (1), 82-91, 2012
1302012
Typical antipsychotic drugs—D2 receptor occupancy and depressive symptoms in schizophrenia
RA Bressan, DC Costa, HM Jones, PJ Ell, LS Pilowsky
Schizophrenia Research 56 (1-2), 31-36, 2002
1172002
Bitopertin in negative symptoms of schizophrenia—results from the phase III FlashLyte and DayLyte studies
D Bugarski-Kirola, T Blaettler, C Arango, WW Fleischhacker, G Garibaldi, ...
Biological psychiatry 82 (1), 8-16, 2017
1142017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20